ReproSURE™ (Ovarian Reserve Profile)

ReproSURE™ is a blood test comprised of Anti-Müllerian Hormone (AMH), Follicle Stimulating Hormone (FSH), and Estradiol designed to provide information about ovarian reserve. Ovarian reserve is a term used to describe a woman's reproductive potential, including the number of oocyttes (eggs) she possesses.

1. ReproSURE is a blood test comprised of AMH, FSH and Estradiol hormones designed to provide information about ovarian reserve.

2. While no laboratory test can predict pregnancy, these ovarian reserve tests assess oocyte quantity and help predict ovarian response to stimulation in order to individualize fertility options including assisted reproductive technology (ART) treatment.

3. Correct timing of blood collection is important. Serum specimen for ReproSURE testing should be collected on day 3 of your menstrual cycle. Day 2 or 4 collection may also be acceptable. FSH and estradiol levels rise and fluctuate after cycle day 3. If FSH and estradiol levels are higher than expected, you may wish to verify the cycle day of the blood collection.

4. These tests are not the sole criteria used to determine appropriateness of ART or any other treatment.

5. These tests do not evaluate egg quality. Egg quality peaks in a woman's twenties and then declines with age.

6. Antral follicle count (AFC) is another measure of egg supply that can be obtained by ultrasound observation.